^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CA3

    i
    Other names: CA3, CIL56

    Associations

    News
    Trials
    Company:
    UT MD Anderson Cancer Center
    Drug class:
    YAP1 inhibitor
    Related drugs:

    Associations

    News
    Trials